Lee's Pharmaceutical Holdings Limited (HKG:0950)
1.410
+0.005 (0.36%)
May 28, 2025, 4:08 PM HKT
HKG:0950 Revenue
In the year 2024, Lee's Pharmaceutical Holdings had annual revenue of 1.40B HKD with 32.95% growth. Lee's Pharmaceutical Holdings had revenue of 741.62M in the half year ending December 31, 2024, with 26.99% growth.
Revenue
1.40B
Revenue Growth
+32.95%
P/S Ratio
0.59
Revenue / Employee
1.37M
Employees
1,022
Market Cap
830.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.40B | 346.94M | 32.95% |
Dec 31, 2023 | 1.05B | -180.11M | -14.61% |
Dec 31, 2022 | 1.23B | -33.01M | -2.61% |
Dec 31, 2021 | 1.27B | 49.44M | 4.06% |
Dec 31, 2020 | 1.22B | -2.20M | -0.18% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
CSPC Pharmaceutical Group | 30.87B |
Akeso | 2.26B |
Sino Biopharmaceutical | 30.72B |